These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Choi JY; Park CS; Kim DJ; Cho MH; Jin BK; Pie JE; Chung WG Neurotoxicology; 2002 Sep; 23(3):367-74. PubMed ID: 12387363 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. Schulz JB; Matthews RT; Muqit MM; Browne SE; Beal MF J Neurochem; 1995 Feb; 64(2):936-9. PubMed ID: 7530297 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice. Muramatsu Y; Kurosaki R; Mikami T; Michimata M; Matsubara M; Imai Y; Kato H; Itoyama Y; Araki T Metab Brain Dis; 2002 Sep; 17(3):169-82. PubMed ID: 12322787 [TBL] [Abstract][Full Text] [Related]
11. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease. Watanabe Y; Kato H; Araki T Metab Brain Dis; 2008 Mar; 23(1):51-69. PubMed ID: 18030609 [TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice. Yokoyama H; Yano R; Aoki E; Kato H; Araki T Metab Brain Dis; 2008 Sep; 23(3):335-49. PubMed ID: 18648914 [TBL] [Abstract][Full Text] [Related]
13. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. Itzhak Y; Ali SF J Neurochem; 1996 Oct; 67(4):1770-3. PubMed ID: 8858965 [TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity. Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147 [TBL] [Abstract][Full Text] [Related]
16. Salicylate protects against MPTP-induced impairments in dopaminergic neurotransmission at the striatal and nigral level in mice. Ferger B; Teismann P; Earl CD; Kuschinsky K; Oertel WH Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):256-61. PubMed ID: 10543426 [TBL] [Abstract][Full Text] [Related]
17. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Itzhak Y; Martin JL; Ali SF Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724 [TBL] [Abstract][Full Text] [Related]
18. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates. Albanese A; Granata R; Gregori B; Piccardi MP; Colosimo C; Tonali P Neuroscience; 1993 Aug; 55(3):823-32. PubMed ID: 8105418 [TBL] [Abstract][Full Text] [Related]
19. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease. Breidert T; Callebert J; Heneka MT; Landreth G; Launay JM; Hirsch EC J Neurochem; 2002 Aug; 82(3):615-24. PubMed ID: 12153485 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity. Di Monte DA; Royland JE; Anderson A; Castagnoli K; Castagnoli N; Langston JW J Neurochem; 1997 Oct; 69(4):1771-3. PubMed ID: 9326308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]